Table 1: Demographic, clinical, and therapeutic characteristics.

 

MT-group (n = 12)

Control-group (n = 12)

Age (years)

46.2

47.2

Male/female

n = 4/n = 8

n = 6/n = 6

HLA-B27 positive

n = 10

n = 6

Disease duration (years)

6.3

9.0

BASDAI

5.43 2.58

5.32 2.07

BASFI

4.53 2.27

4.94 2.87

BAS-G

6.79 1.67

6.29 1.86

Morning stiffness (hours)

1 0.7

0.77 0.75

Peripheral arthritis

n = 5

n = 8

Enthesitis

n = 3

n = 7

Iritis

n = 3

n = 4

Medication

NSAIDs

n = 11

n = 10

DMARDs

n = 5

n = 8

 

MT: manual therapy; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; BASFI: Bath Ankylosing Spondylitis Disease Functional Index;

BAS-G: Bath Ankylosing Spondylitis Patient Global Score; NSAIDs: nonsteroidal antiinflammatory rheumatic drugs, DMARDs: Disease-modifying antirheumatic drugs